Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $24.9 Million - $45.1 Million
388,500 New
388,500 $26 Million
Q1 2022

May 17, 2022

SELL
$94.08 - $130.2 $6.65 Million - $9.21 Million
-70,700 Reduced 51.72%
66,000 $33.8 Million
Q4 2021

Feb 15, 2022

SELL
$129.87 - $162.82 $3.12 Million - $3.91 Million
-24,000 Reduced 14.93%
136,700 $73.4 Million
Q3 2021

Nov 16, 2021

BUY
$106.71 - $143.18 $1.23 Million - $1.65 Million
11,500 Added 7.71%
160,700 $87.9 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $7.68 Million - $10.2 Million
94,800 Added 174.26%
149,200 $63.7 Million
Q1 2021

May 18, 2021

SELL
$84.79 - $104.74 $2.03 Million - $2.5 Million
-23,900 Reduced 30.52%
54,400 $19.6 Million
Q4 2020

Feb 17, 2021

SELL
$78.0 - $104.5 $1.85 Million - $2.48 Million
-23,700 Reduced 23.24%
78,300 $28.9 Million
Q3 2020

Nov 17, 2020

SELL
$95.51 - $112.95 $12.4 Million - $14.6 Million
-129,500 Reduced 55.94%
102,000 $42 Million
Q2 2020

Aug 17, 2020

BUY
$62.68 - $105.34 $12.1 Million - $20.4 Million
193,700 Added 512.43%
231,500 $93.9 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $1.04 Million - $1.65 Million
21,800 Added 136.25%
37,800 $10.2 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $21,972 - $34,374
-600 Reduced 3.61%
16,000 $3.5 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $223,839 - $275,940
6,300 Added 61.17%
16,600 $2.48 Million
Q2 2019

Aug 15, 2019

SELL
$27.84 - $38.92 $1.11 Million - $1.55 Million
-39,900 Reduced 79.48%
10,300 $1.54 Million
Q1 2019

May 16, 2019

BUY
$28.07 - $38.18 $1.25 Million - $1.7 Million
44,400 Added 765.52%
50,200 $5.98 Million
Q4 2018

Feb 15, 2019

SELL
$26.99 - $37.37 $118,756 - $164,428
-4,400 Reduced 43.14%
5,800 $695,000
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $91,065 - $143,208
-3,900 Reduced 27.66%
10,200 $1.46 Million
Q1 2018

May 15, 2018

BUY
$13.06 - $18.54 $184,146 - $261,414
14,100 New
14,100 $1.05 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.